Fort Washington Investment Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$628K Hold
3,300
﹤0.01% 334
2026
Q1
$557K Hold
3,300
﹤0.01% 338
2025
Q4
$557K Hold
3,300
﹤0.01% 326
2025
Q3
$476K Sell
3,300
-710
-18% -$96.9K ﹤0.01% 328
2025
Q2
$507K Sell
4,010
-670
-14% -$82.2K ﹤0.01% 314
2025
Q1
$599K Sell
4,680
-700
-13% -$94.9K ﹤0.01% 308
2024
Q4
$711K Sell
5,380
-150
-3% -$21.1K ﹤0.01% 297
2024
Q3
$805K Hold
5,530
﹤0.01% 292
2024
Q2
$759K Sell
5,530
-105
-2% -$14K ﹤0.01% 301
2024
Q1
$773K Sell
5,635
-75
-1% -$10.2K 0.01% 300
2023
Q4
$776K Sell
5,710
-30
-0.5% -$3.66K 0.01% 289
2023
Q3
$702K Sell
5,740
-120
-2% -$15.3K 0.01% 289
2023
Q2
$744K Sell
5,860
-60
-1% -$7.79K 0.01% 284
2023
Q1
$765K Hold
5,920
0.01% 283
2022
Q4
$777K Hold
5,920
0.01% 285
2022
Q3
$692K Hold
5,920
0.01% 302
2022
Q2
$696K Sell
5,920
-50
-0.8% -$5.93K 0.01% 303
2022
Q1
$778K Sell
5,970
-50
-0.8% -$6.51K ﹤0.01% 337
2021
Q4
$919K Hold
6,020
0.01% 330
2021
Q3
$973K Sell
6,020
-80
-1% -$13.5K 0.01% 317
2021
Q2
$998K Hold
6,100
0.01% 320
2021
Q1
$918K Hold
6,100
0.01% 320
2020
Q4
$924K Sell
6,100
-200
-3% -$28.6K 0.01% 317
2020
Q3
$853K Hold
6,300
0.01% 323
2020
Q2
$861K Buy
6,300
+225
+4% +$28.7K 0.01% 320
2020
Q1
$655K Sell
6,075
-450
-7% -$51.8K 0.01% 308
2019
Q4
$786K Hold
6,525
0.01% 333
2019
Q3
$649K Sell
6,525
-400
-6% -$41.9K 0.01% 366
2019
Q2
$756K Sell
6,925
-2,450
-26% -$261K 0.01% 343
2019
Q1
$1.05M Sell
9,375
-7,623
-45% -$836K 0.01% 317
2018
Q4
$1.64M Buy
16,998
+134
+0.8% +$14.2K 0.02% 290
2018
Q3
$2.06M Sell
16,864
-275
-2% -$32.4K 0.02% 296
2018
Q2
$1.88M Buy
17,139
+1,980
+13% +$212K 0.02% 302
2018
Q1
$1.62M Sell
15,159
-282
-2% -$31.3K 0.02% 329
2017
Q4
$1.65M Buy
15,441
+33
+0.2% +$3.53K 0.02% 352
2017
Q3
$1.71M Sell
15,408
-690
-4% -$73.7K 0.03% 248
2017
Q2
$1.65M Sell
16,098
-54
-0.3% -$5.32K 0.03% 243
2017
Q1
$1.58M Sell
16,152
-96
-0.6% -$9.19K 0.03% 259
2016
Q4
$1.44M Sell
16,248
-840
-5% -$76.5K 0.02% 267
2016
Q3
$1.65M Sell
17,088
-240
-1% -$22.8K 0.03% 224
2016
Q2
$1.49M Buy
17,328
+96
+0.6% +$8.61K 0.03% 236
2016
Q1
$1.5M Buy
+17,232
New +$1.54M 0.03% 239
2015
Q4
Sell
-18,801
Closed -$1.9M 403
2015
Q3
$1.9M Sell
18,801
-465
-2% -$55.8K 0.04% 216
2015
Q2
$2.37M Buy
19,266
+75
+0.4% +$8.98K 0.04% 194
2015
Q1
$2.2M Buy
19,191
+1,455
+8% +$160K 0.04% 199
2014
Q4
$1.79M Buy
17,736
+390
+2% +$37.9K 0.04% 214
2014
Q3
$1.58M Sell
17,346
-315
-2% -$27.6K 0.03% 231
2014
Q2
$1.51M Buy
17,661
+765
+5% +$60.3K 0.03% 246
2014
Q1
$1.33M Sell
16,896
-375
-2% -$31.2K 0.03% 239
2013
Q4
$1.31M Sell
17,271
-960
-5% -$68.1K 0.03% 310
2013
Q3
$1.27M Buy
18,231
+630
+4% +$41.3K 0.03% 310
2013
Q2
$1.02M Buy
+17,601
New +$1.02M 0.02% 305

Other funds holding IBB

Fort Washington Investment Advisors's IBB Position: Q2 2026 in Review

Fort Washington Investment Advisors held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 3,300 shares worth $628K. The position accounts for ﹤0.01% of the portfolio, ranked #334.

Fort Washington Investment Advisors first reported a position in IBB in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.37M in Q2 2015. 285 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Fort Washington Investment Advisors held 3,300 shares of iShares Biotechnology ETF worth $628K as of Q2 2026.
  • Fort Washington Investment Advisors left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up ﹤0.01% of Fort Washington Investment Advisors's portfolio in Q2 2026, its #334 holding.
  • Fort Washington Investment Advisors first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 52 quarters since.
  • Fort Washington Investment Advisors's iShares Biotechnology ETF position peaked at $2.37M in Q2 2015.
  • 285 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Fort Washington Investment Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.